Literature DB >> 31712844

The Effect of Resection Margin Distance and Invasive Component Size on Recurrence After Sublobar Resection in Patients With Small (≤2 Cm) Lung Adenocarcinoma.

Youngkyu Moon1, Jae Kil Park2, Kyo Young Lee3.   

Abstract

BACKGROUND: When performing sublobar resection for lung cancer, the margin distance should exceed the tumor size. However, instead of total tumor size, the 8th edition TNM staging system has adopted the size of invasive component for the T stage. The aim of this study was to determine whether the prognosis was satisfactory when the resection margin distance was greater than the invasive component size instead of the total tumor size.
METHODS: From 2008 to 2017, 193 consecutive patients were diagnosed with lung adenocarcinoma (invasive component size ≤2 cm) and underwent sublobar resection. We analyzed risk factors for recurrence using clinicopathological factors including margin/invasive component ratio (resection margin distance/invasive component size).
RESULTS: Mean tumor size was 1.4 (±0.5) cm and the mean invasive component size was 0.8 cm (±0.5). In the multivariate analysis, neither resection margin distance (cm) nor margin/tumor ratio (resection margin distance/tumor size) was significant risk factors for recurrence. On the other hand, the margin/invasive component ratio (hazard ratio =0.035, p = 0.043) and the SUVmax (hazard ratio =1.993, p = 0.033) were significant risk factors for recurrence.
CONCLUSIONS: When sublobar resection is performed for small (invasive component size ≤2 cm) adenocarcinomas of the lung, the resection margin distance should be larger than the invasive component size. Sublobar resection is not an appropriate treatment for lung adenocarcinoma with high SUVmax.

Entities:  

Mesh:

Year:  2020        PMID: 31712844     DOI: 10.1007/s00268-019-05276-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  7 in total

Review 1.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Prognosis of wide wedge resection in patients with stage IA1 and IA2 lung adenocarcinoma with total tumor size including the lepidic component greater than 2 cm: a single center retrospective study.

Authors:  Youngkyu Moon; Si Young Choi; Mi Hyoung Moon
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

3.  Is the size of the lepidic component negligible when measuring the size of the tumor to determine the stage of lung adenocarcinoma?

Authors:  Youngkyu Moon
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

4.  Ultra-low-dose intraoperative X-ray imager for minimally invasive surgery: a pilot imaging study.

Authors:  Haewook Park; Kook Nam Han; Byeong Hyeon Choi; Hyunsuk Yoon; Hyun Joon An; Jae Sung Lee; Hyun Koo Kim
Journal:  Transl Lung Cancer Res       Date:  2022-04

5.  Does surgical margin affect recurrence and survival after sublobar pulmonary resection for lung cancer?

Authors:  Weijing Liu; Hongjin Lai; Zihuai Wang; Lunxu Liu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

6.  Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes.

Authors:  Xiaofei Wang; Shuang Yao; Zengtuan Xiao; Jialin Gong; Zuo Liu; Baoai Han; Zhenfa Zhang
Journal:  J Transl Med       Date:  2020-04-01       Impact factor: 5.531

7.  The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection.

Authors:  Si Young Choi; Mi Hyoung Moon; Youngkyu Moon
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.